Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CMS Considers Inherent Reasonableness Rule To Lower Pay For Diabetes Test Supplies

This article was originally published in The Gray Sheet

Executive Summary

The use of a relatively obscure CMS fee-adjustment authority rather than competitive bidding to lower Medicare payment for diabetes testing supplies in the retail setting could be precedent setting.

Advertisement

Related Content

Not-So-Happy New Year: Device Tax Not Addressed In Fiscal Cliff Law
Not-So-Happy New Year: Device Tax Not Addressed In Fiscal Cliff Law
Reimbursement In Brief
Wal-Mart To CMS: Retail, Mail-Order Diabetes Supplies Should Be Paid The Same Rate
States Look To Manufacturer Rebate Programs To Save On Medicaid Diabetes Supplies
States Look To Manufacturer Rebate Programs To Save On Medicaid Diabetes Supplies
CMS In Brief
Access To Diabetic Test Strips Jeopardized In CMS Competitive Bidding Areas
DME Competitive Bidding: 32% Cost-Cutting Expected From Revived Program
CMS Gains Authority To Adjust “Grossly” Unsuited Payments Under Final Rule

Topics

Advertisement
UsernamePublicRestriction

Register

MT031420

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel